3D-printing and Acces to Tele Rehabilitation (Imp&acte3D)

July 7, 2023 updated by: Lieven De Maesschalck

IMPression 3D & ACcès à la Teléréadaptation / 3D-printen en Toegang Tot Telerevalidatie

This study will investigate whether 3D printing of orthoses (night splints and AFO/KAFO for walking, further named as dynamic AFO/KAFO) for the lower limbs can help to improve the limited accessibility to orthopaedic devices in developing countries. The 3D printed orthoses will be assessed for effectiveness, cost and feasibility. Measurement and manufacture of the orthoses is also supported remotely via video conferencing.

Study Overview

Detailed Description

Specifically, the study is being conducted in 3 West African countries: Togo, Niger and Mali. A total of 4 orthopaedic centres are involved, whereby an equal number of patients are recruited everywhere.

There are 2 groups of patients, those who need a (knee) ankle-foot orthosis to move around (dynamic AFO/KAFO) and those who need a night splint to correct the ankle or knee position. All patients in the study will have a treatment route involving fitting a new traditional orthosis and a new 3D printed orthosis. The order of application of both treatments will be randomised in a crossover design. Patients will be measured at baseline after the first treatment period (3 weeks) and after the second treatment period (6 weeks). The primary outcome measures are different for both groups of patients: the walking speed when performing the 10-metre walk test in the patients wearing the dynamic AFO/KAFO, and the measured angle (of knee or ankle) in the patients wearing a night splint.

Study Type

Interventional

Enrollment (Actual)

79

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bamako, Mali
        • CNAOM
      • Niamey, Niger
        • Centre Hospitalier Universitaire de Niamey
      • Dapaong, Togo
        • CRAO
      • Lomé, Togo
        • CNAO

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Pathology: foot stance abnormality
  • Both unilateral and bilateral orthoses are included
  • Pathology: genu varum

Exclusion Criteria:

  • Patient is already wearing a night splint
  • The patient cannot stand upright
  • The patient is pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AFO (ankle foot orthosis) dynamic and correctional
Groep A with AFO (ankle foot orthosis) dynamic and correctional
3D treatment (AFO will be printed) versus traditional made AFO
No Intervention: AFO or KAFO (knee ankle foot orthosis) correctional
Groep B with AFO or KAFO (knee ankle foot orthosis) and only correctional
Experimental: KAFO dynamic and correctional
Groep C with KAFO dynamic and correctional
3D treatment (KAFO will be printed) versus traditional made KAFO
No Intervention: KAFO correctional
Groep D with KAFO only correctional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10 meter walk test
Time Frame: 5 weeks
10 meter walk test
5 weeks
knee angle test
Time Frame: 5 weeks
Knee angle test
5 weeks
Ankle angle test
Time Frame: 5 weeks
Ankle angle test
5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
OPUS questionnnaire
Time Frame: 5 weeks
OPUS questionnnaire (measure on 5 point Likertscale: Very easy, Easy, Slightly difficult, Very difficult and Cannot do this activity and this for 21 items.
5 weeks
Range of motion
Time Frame: 5 weeks
Range of motion
5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2018

Primary Completion (Actual)

October 31, 2018

Study Completion (Actual)

April 15, 2019

Study Registration Dates

First Submitted

October 7, 2021

First Submitted That Met QC Criteria

July 7, 2023

First Posted (Actual)

July 17, 2023

Study Record Updates

Last Update Posted (Actual)

July 17, 2023

Last Update Submitted That Met QC Criteria

July 7, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • S65004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthopedic Disorder

Clinical Trials on Ankle Foot Orthosis (AFO)

3
Subscribe